| | | | | | | | | Sponsored | | Specifically designed for the high-throughput laboratory, Shimadzu’s multiplex LC-MS/MS incorporates unique LC-MS multiplexing technology using dedicated sample introduction streams for continuous operation of the mass spectrometer. Combined with dedicated software that provides an automated single point of control, Nexera QX significantly increases laboratory throughput and profitability. |
|
|
| | |
| |
| | |
|
|
| | | | | | At ADLM 2026, Thermo Fisher showcased advances in connective tissue disease and multiple myeloma testing. In this exclusive Q&A, Thermo Fisher experts discuss how automation and targeted biomarkers can streamline laboratory workflows and provide more actionable information for clinicians. |
|
|
|
| |
| | |
|
|
| | | | | | This analysis examines publicly available essential functions across U.S. phlebotomy programs, identifying five core domains that support student readiness and patient safety while emphasizing the need for standardized, inclusive language aligned with ADA principles. |
|
|
|
| |
| | |
|
|
| | | | | | Leica Biosystems, a Danaher company, announced multiple U.S. Food and Drug Administration (FDA) 510(k) clearances that strengthen its connected clinical digital pathology portfolio, including the industry’s first standalone, AI-assisted quality control software. |
|
|
|
| |
| | |
|
|
| | | | | | Moderna’s new seasonal influenza vaccine, mFLUSIVA, has received U.S. Food and Drug Administration (FDA) approval for adults aged 50 and older, according to an announcement from Moderna. The company anticipates having the vaccine ready for the upcoming 2026-2027 flu season. |
|
|
|
| |
| | |
|
|
| | | | | | The White House published an Executive Order (EO) on August 10 from President Trump regarding childhood vaccine recommendations in the U.S. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
